Literature DB >> 14511771

Expression and subcellular distribution of Bcl-2 and BAX proteins in serum-starved human keratinocytes and mouth carcinoma epidermoid cultures.

F Papa1, S Scacco, R Vergari, M De Benedittis, M Petruzzi, L Lo Muzio, R Serpico.   

Abstract

Squamous cell carcinoma (SSC) is the most frequent malignant tumor of the oral cavity. Aberration of programmed cell death is thought to participate in cancer. Using specific antibodies a study of the expression and subcellular distribution of Bcl-2, BAX, caspase-3 and cytochrome c in normal human keratinocytes and mouth carcinoma slowly (HN) and rapidly growing (KB) cells has been carried out. In carcinoma cells depressed expression of BAX, presence in the cytosol of procaspase-3 and absence in this fraction of cytochrome c have been found. PGE2 treatment prevented cell growth depression induced by pro-apoptotic serum starvation both in control and carcinoma cell cultures. It is also shown that PGE2 promoted both in keratinocytes and KB cells expression of Bcl-2, which was accompanied in the first case by increase in its mitochondrial level. These results indicate that in carcinoma cells there is an apparent down regulation of the apoptotic cascade as compared to normal keratinocytes. Thus the possibility that down regulation of apoptosis is associated with promotion of tumor development in the oral mucosa cells seems to be supported by these observations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511771     DOI: 10.1016/s0024-3205(03)00706-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  MIB-1, Bcl-2 and p53 in odontogenic myxomas of the jaws.

Authors:  G Iezzi; A Piattelli; C Rubini; L Artese; M Fioroni; F Carinci
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-10       Impact factor: 2.124

2.  Serum starvation-induces down-regulation of Bcl-2/Bax confers apoptosis in tongue coating-related cells in vitro.

Authors:  Yanhua Huang; Ziyi Fu; Wei Dong; Zhenming Zhang; Jinquan Mu; Junfeng Zhang
Journal:  Mol Med Rep       Date:  2018-01-29       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.